$2.41
-0.09 | -3.60%
-0.09 | -3.60%
Today's Range:
2.39 -
2.50
XOMA Avg. Daily Volume:
1,092,000
05/30/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.50 |
| 52 Week High | 3.14 |
| 52 Week Low | 1.04 |
| Avg. Daily Vol. (Mil) | 1.09 |
| Beta (3 year) | 2.77 |
| Share Related Items | |
| Mkt Cap (Mil) | 170.21 |
| Shares Out (Mil) | 68.08 |
| Float (Mil) | 52.43 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.50 |
| Current Ratio | 4.70 |
| LT Debt/ Equity | 1.72 |
| Total Debt / Equity | 1.87 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 3.24 |
| Price/Book | 8.73 |
| Price/Cash Flow | -3.40 |
| Per Share Data | |
| Earnings | -1.51 |
| Sales | 0.77 |
| Book Value | 0.29 |
| Cash Flow | -0.73 |
| Business Summary | |
|---|---|
| Xoma Ltd is a biopharmaceutical company, which is engaged in the discovery, development and manufacture of therapeutic antibodies and other agents designed to treat inflammatory, autoimmune, infectious and oncological diseases. | |
| General Information | |
| 2910 Seventh Street
Berkeley, CA 94710 |
|
| www.xoma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 157 | |
| CEO: John Varian | |
| Short Interest | |
| Current Month (Mil) | 4.32 |
| Previous Month (Mil) | 3.87 |
| Short Interest Ratio (Days) | 4.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -56.10 |
| Return on Investments | -107.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet